[HTML][HTML] Therapeutic options against the new coronavirus: updated clinical and laboratory evidences

ACL Fernandes, AJM Vale, FP Guzen… - Frontiers in …, 2020 - frontiersin.org
The pandemic caused by the new coronavirus (SARS-Cov-2) has encouraged numerous in
vitro studies and clinical trials around the world, with research groups testing existing drugs …

[PDF][PDF] Pharmacological treatments of covid-19-a review

JM Cherumanalil, J Thayyil - Asian J Pharm Clin Res, 2020 - kmctmedicalcollege.org
Now the world stands in the fight against coronavirus disease 2019 (COVID-19), with its
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …

[HTML][HTML] Systematic and statistical review of coronavirus disease 19 treatment trials

JA Siordia, M Bernaba, K Yoshino, A Ulhaque… - SN comprehensive …, 2020 - Springer
The following systematic review and meta-analysis compile the current data regarding
human controlled COVID-19 treatment trials. An electronic search of the literature compiled …

[HTML][HTML] Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-Infective Therapy …

M Bassetti, DR Giacobbe, S Aliberti, E Barisione… - Clinical Microbiology …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which has rapidly become …

Therapeutic interventions for COVID-19: a living overview of reviews

M Khalili, M Chegeni, S Javadi… - Therapeutic …, 2020 - journals.sagepub.com
Background: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, but safe
and effective treatment options remain unavailable. Numerous systematic reviews of varying …

Review on therapeutic targets for COVID-19: insights from cytokine storm

ML de Mélo Silva Júnior, LMA de Souza… - Postgraduate …, 2021 - academic.oup.com
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
caused the greatest pandemic of our century. Many of the deaths related to it are due to a …

[HTML][HTML] Treatments for COVID-19

HS Andrews, JD Herman… - Annual Review of …, 2024 - annualreviews.org
The treatment for COVID-19 has evolved rapidly since the start of the pandemic and now
consists mainly of antiviral and immunomodulatory agents. Antivirals, such as remdesivir …

Updated approaches against SARS-CoV-2

H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …

COVID-19: a review of potential treatments (corticosteroids, remdesivir, tocilizumab, bamlanivimab/etesevimab, and casirivimab/imdevimab) and pharmacological …

S Nhean, ME Varela, YN Nguyen… - Journal of …, 2023 - journals.sagepub.com
Objectives: In light of the ongoing global pandemic, this paper reviews data on a number of
potential and approved agents for COVID-19 disease management, including …

[HTML][HTML] Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)

C Mussini, M Falcone, S Nozza, C Sagnelli… - Clinical Microbiology …, 2021 - Elsevier
Scope Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
become pandemic, reaching almost one million death worldwide. At present standard …